The Ailliance Post-Market Clinical Study: All Enabling Technologies, Biologics, IDS, and Core Spine Product Collection Read more about The Ailliance Post-Market Clinical Study: All Enabling Technologies, Biologics, IDS, and Core Spine Product Collection
Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut) Read more about Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut)
Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse Bone Graft with an Intervertebral Bo Read more about Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse Bone Graft with an Intervertebral Bo
POWER-UP Trial (Performance Output With Haptics Evaluating Athlete Response and Unrealized Potential) Read more about POWER-UP Trial (Performance Output With Haptics Evaluating Athlete Response and Unrealized Potential)
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial FACILE VT Trial Read more about Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial FACILE VT Trial
An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) Read more about An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
A Randomized, Double-blind, Multicenter Phase Iii Study To Evaluate The Long-term Efficacy And Safety Of Abx464 25 Mg Or 50 Mg Once Daily As A Maintenance Therapy In Subjects With Moderately To Severe Read more about A Randomized, Double-blind, Multicenter Phase Iii Study To Evaluate The Long-term Efficacy And Safety Of Abx464 25 Mg Or 50 Mg Once Daily As A Maintenance Therapy In Subjects With Moderately To Severe
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures Read more about A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Read more about A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer
A Phase III, Double-blind, Randomized Placebo-Controlled Study To Evaluate The Effects Of Dalcetrapib On Cardiovascular (CV) Risk In A Genetically Defined Population With A Recent Acute Coronary Syndr Read more about A Phase III, Double-blind, Randomized Placebo-Controlled Study To Evaluate The Effects Of Dalcetrapib On Cardiovascular (CV) Risk In A Genetically Defined Population With A Recent Acute Coronary Syndr
